Latest Period
Q1 2026
Security Snapshot
Propanc Biopharma, Inc. - Common Stock, par value $0.001 per share (PPCB) Institutional Ownership
CUSIP: 74346N701
13F Institutional Holders and Ownership History from Q3 2025 to Q1 2026
Institutions Reporting
6
Shares (Excl. Options)
462,396
Price
$0.11
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Stock, par value $0.001 per share
- Symbol
- PPCB on Nasdaq
- All holders as of 31 Mar 2026
- Q1 2026
- Total 13F shares
- 462,396
- Total 13F value
- $48,694
- Portfolio coverage rank
- 0%
- Share change
- +333,506
- Value change
- +$17,058
- Number of holders
- 6
- Shares outstanding
- 12,703,253
- SEC-reported price per share
- $0.09
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
2 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- PPCB - Propanc Biopharma, Inc. - Common Stock, par value $0.001 per share is tracked under CUSIP 74346N701.
- 6 institutions reported positions in Q1 2026.
- Schedule 13D/13G significant owner rows are not currently available.
Change
- Holder count moved from 4 to 6 between Q4 2025 and Q1 2026.
- SEC-reported value moved from $69,467 to $48,694.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 6 institutions filings for Q1 2026.
Security key
74346N701
Latest holder period
Q1 2026
13F holders
6
13D/G owners
0
CIK / CUSIP context first
Open Q1 2026 holders
PPCB full holder history
Propanc Biopharma, Inc. SEC filings
Propanc Biopharma, Inc. company facts
Propanc Biopharma, Inc. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 74346N701:
As of 31 Mar 2026, 6 institutional investors reported holding 462,396 shares of Propanc Biopharma, Inc. - Common Stock, par value $0.001 per share (PPCB). This represents 3.6% of the company’s total 12,703,253 outstanding shares.
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
3
Latest
Q1 2026
Rows shown
1-3 of 3